This includes genes involved in cancer progression such as Kif26a, Acer2, Serpine1, Nr1d2, Efnb2 as well as Chst11, which have all previously been shown to be deregulated in various forms of cancer, including lung cancer. This evidence concerns the gene NR1D2 and lung carcinoma.